Similar articles for PMID: 16908892

Year	Number of Results
1992	1
1995	1
1998	2
2000	1
2002	4
2003	1
2004	2
2005	3
2006	8
2007	21
2008	21
2009	9
2012	1
2013	2
2014	2
2018	2
2019	1
2022	1
2023	0

1

Is there another way to take account of noncompliance in randomized controlled trials?

Hewitt CE, Torgerson DJ, Miles JN. Hewitt CE, et al. CMAJ. 2006 Aug 15;175(4):347. doi: 10.1503/cmaj.051625. CMAJ. 2006. PMID: 16908892 Free PMC article. No abstract available.

2

Noncompliance in cancer screening trials.

Gareen IF. Gareen IF. Clin Trials. 2007;4(4):341-9. doi: 10.1177/1740774507081341. Clin Trials. 2007. PMID: 17848495

3

Regarding paper "Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance" by Lui K. J. and Chang K. C.

Vach W. Vach W. Biom J. 2007 Aug;49(4):627-9; author reply 630-1. doi: 10.1002/bimj.200710356. Biom J. 2007. PMID: 17722194 No abstract available.

4

Stratified analysis in randomized trials with noncompliance.

Matsui S. Matsui S. Biometrics. 2005 Sep;61(3):816-23. doi: 10.1111/j.1541-0420.2005.00339.x. Biometrics. 2005. PMID: 16135033

5

Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?

Bria E, Di Maio M, Cuppone F, Nisticò C, Cognetti F, Giannarelli D. Bria E, et al. J Clin Oncol. 2007 Feb 10;25(5):605-6; author reply 606-7. doi: 10.1200/JCO.2006.09.0365. J Clin Oncol. 2007. PMID: 17290074 No abstract available.

6

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).

Corder AP, Iqbal M, Devaraj S. Corder AP, et al. Br J Surg. 2008 Nov;95(11):1428-9; author reply 1429. doi: 10.1002/bjs.6425. Br J Surg. 2008. PMID: 18844282 No abstract available.

7

[Arguments against implementing a population-based screening programme for colorectal cancer].

Bonneux L. Bonneux L. Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1777. Ned Tijdschr Geneeskd. 2008. PMID: 18754310 Dutch.

8

A note on 'The method of handling non-compliance in clinical trials suggested by Sato/Matsuyama'.

Sjölander A. Sjölander A. Stat Med. 2008 Aug 30;27(19):3920-4. doi: 10.1002/sim.3286. Stat Med. 2008. PMID: 18407577 No abstract available.

9

Testing homogeneity of the risk ratio in stratified noncompliance randomized trials.

Lui KJ. Lui KJ. Contemp Clin Trials. 2007 Sep;28(5):614-25. doi: 10.1016/j.cct.2007.02.010. Epub 2007 Mar 6. Contemp Clin Trials. 2007. PMID: 17409026

10

Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach by Yutaka Matsuyama, Statistics in Medicine 2002; 21:675-687.

Lui KJ. Lui KJ. Stat Med. 2007 Nov 10;26(25):4679-83. doi: 10.1002/sim.2829. Stat Med. 2007. PMID: 17278185 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed